发明名称 |
Exendin improves beta-cell response in subjects with impaired glucose tolerance |
摘要 |
A composition for the treatment of impaired glucose tolerance (IGT) including a compound which binds to a receptor for glucagon-like peptide-1, and a pharmaceutical carrier. The amount of the compound present is an effective amount to improve pancreatic beta-cell sensitivity to blood glucose levels in a human with IGT. Also, a method for improving the pattern of insulin secretory responses in a human with IGT by administering to the human a composition comprising a compound which binds to a receptor for glucagon-like peptide-1 and a pharmaceutical carrier.
|
申请公布号 |
US7265087(B1) |
申请公布日期 |
2007.09.04 |
申请号 |
US19990719410 |
申请日期 |
1999.05.07 |
申请人 |
AMYLIN PHARMACEUTICALS, INC. |
发明人 |
GOEKE BURKHARD;BYRNE MARIA;COOLIDGE THOMAS R. |
分类号 |
A61K38/00;A61K38/28;C07K16/00 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|